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Abstract 31 
Study question. Are the risks of hypoplastic left heart syndrome, transposition of great arteries, 32 
tetralogy of Fallot (TOF) and coarctation of the aorta increased in infants conceived by  different 33 
assisted reproductive techniques (ART)? 34 
Study answer. ART, and particularly intracytoplasmic sperm injection (ICSI), are specifically 35 
associated with a higher risk of TOF. 36 
What is already known. ART are associated with an increase in the overall risk of birth defects. 37 
The risk for congenital heart defects (CHD) associated with ART has been evaluated as a whole 38 
but there is limited information on the risks for specific CHD. 39 
Study design, material and methods. We conducted a case-control study using population-40 
based data from the Paris registry of congenital malformations for the period 1987-2009 and a 41 
cohort study of CHD (EPICARD) on 1583 cases of CHD and 4104 malformed controls with no 42 
known associations with ART. ART included ovulation induction only, IVF and ICSI.  43 
Results. Exposure to ART was significantly higher for TOF than controls (6·6 vs. 3·5%, 44 
P=0·002); this was not the case for the other three CHD. ART (all methods combined) were 45 
associated with a 2·4-fold higher odds of TOF after adjustment for maternal characteristics, 46 
paternal age and year of birth (Adjusted OR 2·4, 95% CI 1·5–3·7) with the highest risk 47 
associated with ICSI (Adjusted OR 3·0, 95%CI 1·0-8·9). No statistically significant associations 48 
were found for the other CHD. 49 
Limitations. Our study cannot disentangle to what extent the observed associations between 50 
risk of TOF and ART are due to causal effects of ART and/or the underlying infertility problems 51 
of couples who conceive following ART. 52 
Implications. The developmental basis of the specific association between the risk of TOF and 53 
ART and in particular the possible role of neural crest cells in this association need to be further 54 
investigated.  55 
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Introduction 70 
Assisted reproductive techniques (ART) are known to be associated with a modest increase in 71 
the overall risk of congenital anomalies (Wennerholm et al., 2000; Hansen et al., 2002; 72 
Koivurova et al., 2002; Hansen et al., 2005; Klemetti et al., 2005; Olson et al., 2005; Schieve et 73 
al., 2005). Relatively little specific information exist on the risk of congenital heart defects 74 
(CHD) for foetuses conceived following ART (Anthony et al., 2002; Hansen et al., 2002; 75 
Katalinic et al., 2004; Lie et al., 2005; Zhu et al., 2006; Reefhuis et al., 2009; Tararbit et al., 76 
2011). Available evidence suggest an overall risk for CHD in relation to ART that is comparable 77 
to that found for all congenital anomalies combined (OR~1·4-1·5) (Hansen et al., 2005; Tararbit 78 
et al., 2011). Specific associations between different methods of ART and categories of CHD 79 
have also been reported by our group (Tararbit et al., 2011) using a subset of the data used in the 80 
present study.  81 
However, previous studies have mostly examined the risk of CHD in relation to ART for all 82 
CHD combined or for broad categories of CHD rather than for specific CHD. Moreover, the 83 
associations between different methods of ART and specific CHD have not been examined. 84 
Assessment of such specific associations is important as known teratogens are generally 85 
associated with the risk of one or a few specific malformations. Furthermore, specific 86 
associations between types of CHD and ART may provide clues about the underlying 87 
mechanism of the higher risk of congenital malformations in foetuses conceived following ART. 88 
Using population-based data from the Paris registry of congenital malformations and a cohort 89 
study of children with CHD (the EPICARD study), we estimated the risks for four major 90 
specific CHD: hypoplastic left heart syndrome (HLHS), transposition of great arteries (TGA), 91 
tetralogy of Fallot (TOF), and coarctation of the aorta (CoA) in relation to different methods of 92 
ART.  93 
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Material and methods 94 
Data sources 95 
Two sources of data were used for this study: 1) the Paris registry of congenital malformations 96 
and 2) the EPICARD study (Epidemiological study on the outcomes for congenital heart 97 
diseases). These two sources of data are briefly described below.  98 
 99 
The Paris registry of congenital malformations 100 
Since 1981, the Paris registry of congenital malformations registers all cases of birth defects and 101 
chromosomal anomalies among live-births, still-births (≥ 22 weeks of gestation), and pregnancy 102 
terminations. The registry covers the population of women who live in the Greater Paris area 103 
(Paris and its surrounding suburb) and deliver or have a termination of pregnancy for foetal 104 
anomaly in a Parisian maternity unit. The annual number of deliveries in our population is about 105 
38,000.  106 
The Paris registry is a member of the European network of registries of congenital 107 
malformations (European Surveillance of Congenital Anomalies, EUROCAT) and of the 108 
International clearinghouse for birth defects surveillance and research (Eurocat special report, 109 
2009; Cocchi et al., 2010;  Greenlees et al., 2011; Khoshnood et al.,2011). The registry follows 110 
the EUROCAT methodology and quality of data is routinely monitored by both EUROCAT and 111 
the French National Committee of Registries. Review of procedures regarding confidentiality of 112 
data is overseen by both the National Committee of Registries and the National Committee of 113 
Informatics and Freedom (CNIL). Data are based on medical records and are collected from 114 
several sources including maternity units, neonatology wards, cytogenetic, and pathology 115 
services.  116 
In the present study, data from the registry corresponded to the period January 1st 1987 to 117 
December 31st 2009 as the first case of a malformation with exposure to in vitro fertilization  118 
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occurred in 1987 and 2009 was the last year for which data were available at the time of the 119 
study. 120 
 121 
EPICARD 122 
The EPICARD study is an on-going prospective cohort study of all children with a CHD 123 
(Khoshnood et al., 2012) born to women living in the Greater Paris area (Paris and its 124 
surrounding suburbs) between 2005 and 2008 regardless of the place of delivery (N = 317,538 125 
births). The principal objectives of the study are to use population-based data from a large 126 
cohort of patients with CHD to: i) estimate the total and live birth prevalence, ii) examine timing 127 
of diagnosis and assess medical and surgical management of children with CHD, iii) evaluate 128 
neonatal mortality and morbidity and neuro-developmental outcomes of children with CHD;  129 
and iv) identify the factors associated with their health outcomes, especially the role of events 130 
during the neonatal period and of the initial medical and surgical management. All cases (live 131 
births, pregnancy terminations, foetal deaths) diagnosed in the prenatal period or up to one year 132 
of age in the birth cohorts between May 1st 2005 and April 30th 2008 were eligible for inclusion. 133 
The total number of cases of CHD included in the study was 2867, including 2348 live births 134 
(82%), 466 pregnancy terminations (16·2%) and 53 foetal deaths (1·8%). Diagnoses were 135 
confirmed in specialized paediatric cardiology departments and for the majority of pregnancy 136 
terminations and foetal deaths by a foetopathologist examination. For others in which a 137 
pathology exam could not be done, the diagnoses were confirmed by consensus by a paediatric 138 
cardiologist and a specialist in echocardiography in the study group based on results of prenatal 139 
echocardiography examination.   140 
 141 
Methods 142 
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A case-control study with malformed controls was performed. Cases were foetuses/children with 143 
hypoplastic left heart syndrome (HLHS), transposition of great arteries (TGA), tetralogy of 144 
Fallot (TOF) and coarctation of the aorta (CoA). Cases included in both the Paris registry and 145 
the EPICARD study were counted once. Malformed controls were isolated congenital defects 146 
other than CHD for which no evidence of an association with ART was found in literature. As 147 
recommended by Hook (1993), we selected a wide spectrum of heterogeneous birth defects as 148 
controls in order to decrease the risk of selection bias due to shared etiologic factors between 149 
cases and controls (Swan et al., 1992; Lieff et al., 1999). The malformations in the control group 150 
comprised cases of club-foot, angioma, skin abnormality, polydactyly, syndactyly and 151 
congenital hip dislocation in the Paris registry.  152 
The risk (odds) of each CHD in relation to ART was the main outcome measure. Data on 153 
exposure to ART were obtained from medical records. The same procedure for data collection 154 
and coding was used for information on ART in the two datasets (Paris registry and EPICARD) 155 
used in this study. Exposure to ART included the following categories: ovulation induction (OI) 156 
only, IVF, and ICSI. Exposure to ART was assessed as: i) a binary variable (ART yes/no) , ii) a 157 
variable in four categories (no ART, OI, IVF, ICSI) and iii) a variable combining IVF and ICSI 158 
(IVF + ICSI) in a single category. 159 
Potential confounding factors considered were maternal characteristics (age, occupation and 160 
geographic origin), paternal age, and year of birth (or pregnancy termination). Although their 161 
exact relations to the risk for specific CHD are not well known, these factors are associated with 162 
both exposure to ART and prevalence of birth defects in general (Vrijheid et al., 2000).Maternal 163 
occupation was coded in five categories (professional, intermediate, administrative/public 164 
service, other, and none) following the French National Institute of Statistics and Economic 165 
Studies (INSEE) classification. Geographic origin was coded in four categories: French, North 166 
African, Sub-Saharan African, and other countries. 167 
 168 
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 169 
Statistical analysis 170 
The odds of each of the four specific CHD vs. controls in relation to ART was estimated using 171 
logistic regression models, after taking into account year of birth, maternal characteristics (age, 172 
occupation and geographic origin), and paternal age. Paternal age was missing for 20·6% of the 173 
study population. We used multiple imputation (Little and Rubin, 2002) for missing data on 174 
paternal age. Paternal age was imputed in twenty sets of data for each CHD separately using the 175 
case/control status, exposure to ART, maternal age, and year of birth/termination. The pooled 176 
(over the 20 datasets) adjusted ORs for the association between ART and risk of each specific 177 
CHD were estimated using the method described by Little and Rubin (2002). In order to explore 178 
the possible role of multiple pregnancies in the association between ART and CHD, we also 179 
conducted analyses with further adjustment for multiple pregnancies and tested for any 180 
interactions effect between multiple pregnancies and ART. 181 
The statistical significance level was set at α = 0.05 and all tests were two-sided.  182 
Analyses were done with Stata 11 software (Statacorp, Texas, USA).      183 
 184 
Ethics approval 185 
No specific ethical approval was needed for this particular analysis. The French National 186 
Committee of Informatics and Freedom (CNIL) has authorised the surveillance and research 187 
activities of the registry using anonymous data and has approved the EPICARD study. 188 
  9 
 
Results 189 
Study population 190 
After excluding cases with missing data on ART (3% of cases), the study population comprised 191 
353 cases of HLHS, 444 cases of TGA, 395 cases of TOF and 391 cases of CoA. Approximately 192 
14% of cases of HLHS, 3% of TGA, 20% of TOF and 10% of CoA were associated with 193 
chromosomal anomalies. The study population included 4104 malformed controls with complete 194 
information on ART, which comprised 1436 with congenital hip dislocation, 824 with club-foot, 195 
782 with polydactyly, 517 with angioma, 381 with skin abnormality, and 164 with syndactyly 196 
with complete information on ART; 3% of controls had missing data on ART.  197 
Table 1 summarises the results of the comparison of the maternal, paternal and pregnancy 198 
characteristics of cases of CHD (all four specific CHD combined) and controls. Overall, 199 
mothers of cases of CHD were older, more likely to be from North Africa and in the 200 
occupational category "none" as compared with mothers of controls. Still births and 201 
terminations of pregnancy for foetal anomaly were more frequent for cases of CHD than 202 
controls.  203 
When comparisons of the characteristics of cases and controls were done for the four defects 204 
separately (detailed results not shown – available from authors), for CHD other than TOF, the 205 
characteristics of cases and controls were for the most part comparable, except that mothers of 206 
cases of CoA were more likely to be from North Africa than controls. Most sociodemographic 207 
characteristics were different between cases of TOF and controls. Mothers of cases of TOF were 208 
significantly older and more likely to be from North Africa than controls. Mothers of cases of 209 
TOF were also more likely to be in the occupational category “none” than controls (data not 210 
shown).  211 
 212 
Risk of CHD associated with ART 213 
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All cases 214 
Exposure to ART (all methods combined, Table 2) was significantly higher for cases of TOF 215 
than controls (6·6% vs. 3·5%, p=0·002). Exposure to the different methods of ART (data not 216 
shown) was also significantly different between cases of TOF and controls, in particular 2·5% of 217 
TOF were born following IVF vs. 1·3% of controls and 1·3% of TOF were born following ICSI 218 
vs. 0·3% of controls (p=0·004). Exposure to ART was not associated with a significantly higher 219 
risk of other CHD. 220 
Exposure to ART was associated with a 2·4-fold increase in the maternal characteristics and 221 
year of birth-adjusted odds of TOF (Adjusted OR= 2·4, 95%CI 1·5 – 3·7) (Table 3). The odds of 222 
TOF associated with ART remained similar after further adjustment for paternal age. In contrast, 223 
ART were not associated with statistically significant increases in the risks of HLHS, TGA or 224 
CoA and the ORs were generally close to the null value (Table 3). All three methods of ART 225 
were associated with significantly higher odds of TOF (Table 4). In particular, ICSI was 226 
associated with a three-fold higher odds of TOF after adjustment for maternal characteristics and 227 
year of birth (Adjusted OR= 3·0, 95%CI 1·0-8·9). There was no evidence that IVF was 228 
associated with a higher odds of TOF as compared with OI (for IVF: Adjusted OR=2·0, 95%CI 229 
1·0 – 4·2; for OI: Adjusted OR= 2·5, 95%CI 1·3 – 4·8). For the other three specific CHD, no 230 
statistically significant associations were observed. Further adjustment for paternal age using the 231 
multiple imputation estimates did not modify appreciably the above estimates (data not shown). 232 
 233 
Cases without associated chromosomal anomalies 234 
Tables 3 and 5 show the results of the analyses for the associations between the risks of the four 235 
CHD and ART (all methods combined, Table 3) and separately for different methods of ART 236 
(Table 5) for the subset of cases without associated chromosomal anomalies. All estimates were 237 
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essentially the same as those found for all cases combined (i.e. when cases of each specific CHD 238 
with and without associated chromosomal anomalies were analysed together). 239 
Results of the analyses, which included further adjustment for multiple pregnancies were 240 
essentially the same as those found without adjustment for multiple pregnancies (data not 241 
shown). We found no statistically significant interaction effects between ART and multiple 242 
pregnancies for any of the four CHD (data not shown). 243 
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Discussion 244 
Using population-based data on nearly 1600 cases of specific congenital heart defects (CHD), 245 
we assessed the risk of four specific CHD in relation to assisted reproductive techniques (ART). 246 
We found that ART (all methods combined) were associated with a 2·4-fold increased risk of 247 
tetralogy of Fallot (TOF), after taking into account maternal age, occupation, geographic origin, 248 
paternal age, and year of birth. In particular, ICSI was associated with a three-fold higher 249 
adjusted odds of TOF. In contrast, we did not find any statistically significant increases in the 250 
risk of CHD in relation to ART for the other CHD in our study, i.e., hypoplastic left heart 251 
syndrome (HLHS), transposition of the great arteries (TGA), and coarctation of the aorta (CoA). 252 
Risk estimates were comparable when cases with chromosomal anomalies were excluded, 253 
suggesting that the associations between ART and TOF are not due to the association of the 254 
latter with chromosomal anomalies. Further adjustement for multiple pregnancies did not 255 
substantially modify our results. 256 
On the basis of our findings, we calculated attributable risk fractions, which would represent the 257 
proportion of cases of TOF that may be caused by ART, or equivalently, the proportion of cases 258 
of TOF that would be avoided were the exposure to ART removed ceteris paribus, „if‟ the 259 
association we found between the risk of TOF and ART can be assumed to represent a causal 260 
relation (this may of course not be the case in part for reasons that are discussed further below). 261 
The attributable risk fraction estimates suggested in particular that around 6.5% of the TOF may 262 
have been caused by ART (all methods combined) and 2% by ICSI.  263 
Our study has certain limitations. We had limited power to detect OR lower than two in the 264 
association between ART (for all methods combined) and specific CHD and three in case of the 265 
different methods of ART. Therefore, our study may have had insufficient power to detect 266 
statistically significant associations for other CHD.  267 
The models used to estimate the odds ratios for the different defects in relation to ART were not 268 
nested (i.e., were separate models) and we did not formally test the statistical significance of 269 
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differences in the odds ratios for one defect vs. another. The associations were not statistically 270 
significant for any of the defects except for TOF, whereas the numbers of cases for the other 271 
CHD were comparable to those of TOF. 272 
A potential source of bias in our study is related to the use of malformed controls (Swan et al., 273 
1992; Lieff et al., 1999). The main advantage of using malformed controls is to reduce the risk 274 
of recall or other sources of information bias. But malformed controls may also be a source of 275 
selection bias if malformations included as controls are either directly or indirectly associated 276 
with ART. Risks could be under (over)-estimated if malformations included in the control group 277 
occur more (less) frequently in foetuses conceived following ART. By selecting a heterogeneous 278 
group of malformations with no known association with ART, as recommended by Hook (1993), 279 
we aimed to minimize such bias. However, the possibility of residual bias due to shared 280 
aetiologies between cases and malformed controls cannot be excluded.  281 
A differential misclassification bias for exposure assessment cannot be excluded if exposure to 282 
ART is ascertained in a different way for cases and controls. However, we have no reason to 283 
believe that ART may have been ascertained differentially for cases of TOF vs. the other CHD 284 
examined in our study. 285 
We had a relatively high proportion of missing data on paternal age. The latter is known to be 286 
associated with ART and more specifically with ICSI. Estimates for ICSI could therefore be 287 
biased if distribution of paternal age was different for subjects with missing data. We used 288 
multiple imputations for imputing missing paternal age using case/control status, exposure to 289 
ART, maternal age and year of birth and adjustment for paternal age did not appreciably change 290 
our results. However, residual bias due to other paternal characteristics cannot be excluded. 291 
The question of multiple pregnancies and its association with both ART and the risk of 292 
congenital anomalies is an important issue to consider. There is evidence suggesting that 293 
multiple pregnancies may be associated with a higher risk of congenital anomalies 294 
(Mastroiacovo, et al., 1999; Glinianaia et al., 2008). This may specifically be the case for CHD, 295 
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although relatively little, and at times contradictory, information exist on the associations 296 
between multiple pregnancies and CHD (Manning et al., 2006; Bahtiyar et al., 2007; Campbell 297 
et al., 2009). Moreover, it is not clear to what extent any association between multiple 298 
pregnancies and CHD may in fact be due to ART. Our results remained similar after further 299 
adjustment for multiple pregnancies and we did not find any statistically significant interaction 300 
effects between ART and multiple pregnancies for any of the CHD, although this may have been 301 
due to limited power of our study for detecting interaction effects. In any case, none of the 302 
above precludes the possibility that multiple pregnancies may be on the causal pathway between 303 
ART and CHD. It is worth noting however that the public health impact of ART on the risk for 304 
birth defects, including that of TOF found in our study, includes all (singleton and multiple) 305 
pregnancies.  306 
Specific associations between ART and certain categories of CHD, particularly the so-called 307 
conotruncal defects, which include TOF, have been reported (Reefhuis et al., 2009; Tararbit et 308 
al., 2001). In a recent study (Tararbit et al., 2011), the risk of CHD associated with ART was 309 
also shown to vary more generally for different methods of ART and categories of CHD defined 310 
based on anatomic and clinical criteria (Houyel et al., 2011). In particular, the authors found a 311 
stronger association between ICSI and the category “Malformations of the outflow tracts and 312 
ventriculoarterial connections” that comprised, among other CHD, the conotruncal defects.   313 
The developmental origins of TOF are complex and not fully understood but they may involve 314 
abnormal development of neural crest cells. None of the other three CHD studied is known to be 315 
of cardiac neural crest origin. In particular TGA which is a defect of the outflow tract does not 316 
belong to the group of the conotruncal defects (Houyel et al., 2011) and migration/proliferation 317 
of neural crest cell appear to be normal in this condition (Bajolle et al., 2006). In order to further 318 
investigate, the hypothesis of the involvement of neural crest cells in the association between 319 
TOF and ART, we assessed the risk for other, rarer CHD thought to be of neural crest origin 320 
(TOF with pulmonary atresia, TOF with absent pulmonary valve, and common arterial trunk). 321 
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We found an increased overall risk associated with ART (data not shown) but the confidence 322 
intervals were wide due to small sample sizes.  323 
Given the uncertainties about both the developmental origins of cardiac defects and possible 324 
effects of ART on foetal development, the hypothesis of a potential implication of neural crest 325 
cells in the association between ART and TOF must be regarded as very tentative and no more 326 
than a reasonable speculation. Future observational and experimental studies using other designs 327 
(e.g., animal studies, genetic studies, fundamental research in biology of reproduction / ART as 328 
well as additional epidemiological studies) are needed to both further assess our observations 329 
and in order to understand the possible underlying mechanisms of the association between the 330 
risk of TOF and ART.  331 
In conclusion, we found that cases of TOF were more likely to have been conceived following 332 
ART when compared with controls. ART were associated with a 2·4-fold higher risk of TOF 333 
after adjustment for maternal age, occupation, geographic origin, paternal age and year of birth; 334 
ICSI was specifically associated with a three-fold higher risk of TOF.  In contrast, we did not 335 
find statistically significant associations between ART and HLHS, TGA or CoA and most ORs 336 
were close to the null value. Our study cannot disentangle to what extent the observed 337 
associations between risk of TOF and ART may be due to any causal effects of ART and/or the 338 
underlying infertility problems of couples who conceive following ART. Nevertheless, the 339 
developmental basis of the specific association between risk of TOF and ART, particularly ICSI, 340 
and the potential implication of neural crest cells in this association, need to be further 341 
investigated.  342 
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n %
§ n %
§
Age (years)
   mean (SD)
   median (p25-p75)
   <20 59 1·4 22 1·4
   20 - 29 1809 42·8 654 40·1
   30 - 34 1434 33·9 531 32·6
   35 - 39 722 17·1 316 19·4
   ≥ 40 203 4·8 107 6·6
   missing* 23 0·5 12 0·7
Geographic origin
   France 2412 57·9 882 54·5
   North Africa 433 10·4 247 15·3
   Subsaharan Africa 550 13·2 163 10·1
   Other 770 18·5 327 20·2
   missing* 85 2·0 23 1·4
Occupation 
   none 1083 26·3 440 29·7
   professional 997 24·2 343 23·2
   intermediate 856 20·8 263 17·8
   administrative/public service 852 20·7 249 16·8
   other 330 8·0 185 12·5
   missing* 132 3·1 162 9·9
Age (years)
   mean (SD)
   median (p25-p75)
   <20 5 0·1 3 0·2
   20 - 29 890 25·8 277 22·6
   30 - 34 1198 34·7 422 34·4
   35 - 39 734 21·3 281 22·9
   ≥ 40 623 18·1 244 19·9
   missing* 800 18·8 415 25·3
Multiplicity
   singletons 2768 96·1 1382 95·8
   twins 103 3·6 57 4·0
   triplets 8 0·3 3 0·2
Outcome
   still-births 7 0·2 46 2·8
   live-births 4231 99·6 1074 65·4
   pregnancy terminations 12 0·3 522 31·8
<0·001
Mother
30 (27 - 34) 31 (27 - 35)
* % of missing data calculated with the total number of cases or controls as a denominator
33 (29 - 38) 33 (30 - 38)
§ % calculated with the total of cases or controls without missing data as a denominator 
0·011
<0·001
<0·001
Pregnancy
0·756
Father
33·9 (6·6) 34·4 (6·7)
0·133
Table 1. Associations between predictor variables and case/control status.
characteristics
controls cases
p
30·4 (5·2) 30·9 (5·5)
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N % exposed to ART p
†
Hypoplastic left heart syndrome 353 2.8 0.491
Transposition of the great arteries 444 2.7 0.363
Tetralogy of Fallot 395 6.6 0.002
Coarctation of the aorta 391 3.3 0.831
Hypoplastic left heart syndrome 303 2.6 0.413
Transposition of the great arteries 430 2.8 0.423
Tetralogy of Fallot 315 7.3 0.001
Coarctation of the aorta 350 3.7 0.860
* The following malformations were used as controls: club-foot, angioma, skin abnormality, polydactyly, syndactyly and congenital hip 
dislocation. 
† CoŵparisoŶ of the proportioŶ of ĐhildreŶ/fetuses ĐoŶĐeiǀed after ART ďetǁeeŶ the speĐifiĐ CHD aŶd the ŵalforŵed ĐoŶtrols.
4 104 3.5
Table 2. Numbers of cases and controls and proportions of fetuses conceived after Assisted Reproductive Technologies (ART). 
Controls *
All cases
Cases without chromosomal anomalies
450 
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CHD ART Unadjusted OR* 95% CI
Maternal              
Adjusted† OR* 95% CI
Hypoplastic left heart syndrome None 1.0 ref. 1.0 ref.
All methods combined 0.8 0.4 - 1.5 0.8 0.4 - 1.8
Transposition of the great arteries None 1.0 ref. 1.0 ref.
All methods combined 0.8 0.4 - 1.4 0.7 0.4 - 1.4
Tetralogy of Fallot None 1.0 ref. 1.0 ref.
All methods combined 1.9 1.3 - 3.0 2.4 1.5 - 3.7
Coarctation of the aorta None 1.0 ref. 1.0 ref.
All methods combined 0.9 0.5 - 1.7 1.1 0.6 - 2.0
Hypoplastic left heart syndrome None 1.0 ref. 1.0 ref.
All methods combined 0.7 0.4 - 1.5 0.8 0.3 - 1.7
Transposition of the great arteries None 1.0 ref. 1.0 ref.
All methods combined 0.8 0.4 - 1.4 0.7 0.4 - 1.4
Tetralogy of Fallot None 1.0 ref. 1.0 ref.
All methods combined 2.2 1.4 - 3.4 2.6 1.6 - 4.2
Coarctation of the aorta None 1.0 ref. 1.0 ref.
All methods combined 1.1 0.6 - 1.9 1.2 0.6 - 2.2
Table 3. Logistic regression analyses of the associations between assisted reproductive technologies (ART, all methods combined) and four specific congenital heart defects (CHD).
All cases
Cases without chromosomal anomalies
* Odds ratios (OR) represent the odds of a birth (including live births, stillbirths and pregnancy terminations) with congenital heart defect (cases) relative to the odds of a birth with one of 
the malformed controls (club-foot, angioma, skin abnormality, polydactyly, syndactyly and congenital hip dislocation).
†Adjusted for ŵaterŶal age, geographiĐ origiŶ, oĐĐupatioŶ aŶd year of ďirth.
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CHD ART Unadjusted OR* 95% CI 95% CI
Hypoplastic left heart syndrome None 1.0 ref. 1.0 ref.
Ovulation induction only 0.7 0.3 - 1.9 0.9 0.3 - 2.5
IVF 0.6 0.2 - 2.0 0.5 0.1 - 2.3
ICSI 1.8 0.4 - 7.9 1.6 0.3 - 7.2
IVF + ICSI 0.8 0.3 - 2.1 0.8 0.3 - 2.3
Transposition of the great arteries None 1.0 ref. 1.0 ref.
Ovulation induction only 0.6 0.2 - 1.5 0.6 0.2 - 1.7
IVF 1.2 0.5 - 2.6 1.0 0.4 - 2.5
ICSI / / / /
IVF + ICSI / / / /
Tetralogy of Fallot None 1.0 ref. 1.0 ref.
Ovulation induction only 1.5 0.8 - 2.9 2.5 1.3 - 4.8
IVF 2.0 1.0 - 3.9 2.0 1.0 - 4.2
ICSI 4.1 1.5 - 11.6 3.0 1.0 - 8.9
IVF + ICSI 2.4 1.3 - 4.2 2.3 1.2 - 4.2
Coarctation of the aorta None 1.0 ref. 1.0 ref.
Ovulation induction only 0.7 0.3 - 1.7 1.0 0.4 - 2.6
IVF 1.0 0.4 - 2.4 1.1 0.4 - 2.9
ICSI 2.4 0.7 - 8.5 1.2 0.2 - 5.6
IVF + ICSI 1.2 0.6 - 2.6 1.1 0.5 - 2.6
†Adjusted for ŵaterŶal age, geographiĐ origiŶ, oĐĐupatioŶ aŶd year of ďirth.
Table 4. Logistic regression analyses of the associations between the different methods of assisted reproductive technologies (ART) and four 
specific congenital heart defects (CHD).
   Maternal        
Adjusted† OR*
* Odds ratios (OR) represent the odds of a birth (including live births, stillbirths and pregnancy terminations) with congenital heart defect (cases) 
relative to the odds of a birth with one of the malformed controls (club-foot, angioma, skin abnormality, polydactyly, syndactyly and congenital 
hip dislocation).
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CHD ART Unadjusted OR* 95% CI 95% CI
Hypoplastic left heart syndrome None 1.0 ref. 1.0 ref.
Ovulation induction only 0.7 0.3 - 1.9 0.8 0.2 - 2.5
IVF 0.5 0.1 - 2.0 0.3 0.0 - 2.4
ICSI 2.1 0.5 - 9.2 1.8 0.4 - 8.4
IVF + ICSI 0.8 0.3 - 2.2 0.7 0.2 - 2.3
Transposition of the great arteries None 1.0 ref. 1.0 ref.
Ovulation induction only 0.6 0.2 - 1.5 0.6 0.2 - 1.8
IVF 1.2 0.5 - 2.7 1.1 0.5 - 2.6
ICSI / / / /
IVF + ICSI / / / /
Tetralogy of Fallot None 1.0 ref. 1.0 ref.
Ovulation induction only 1.6 0.8 - 3.2 2.3 1.1 - 4.8
IVF 2.2 1.1 - 4.5 2.5 1.2 - 5.2
ICSI 5.2 1.8 - 14.7 3.7 1.3 - 10.9
IVF + ICSI 2.8 1.6 - 5.0 2.8 1.5 - 5.2
Coarctation of the aorta None 1.0 ref. 1.0 ref.
Ovulation induction only 0.8 0.3 - 1.9 1.1 0.4 - 2.8
IVF 1.1 0.4 - 2.7 1.3 0.5 - 3.3
ICSI 2.7 0.8 - 9.6 1.3 0.3 - 6.1
IVF + ICSI 1.4 0.7 - 2.9 1.3 0.6 - 2.9
†Adjusted for ŵaterŶal age, geographiĐ origiŶ, oĐĐupatioŶ aŶd year of ďirth.
Table 5. Logistic regression analyses of the associations between assisted reproductive technologies (ART) and four specific congenital heart 
defects (CHD) without associated chromosomal anomalies.
     Maternal        
Adjusted† OR*
* Odds ratios (OR) represent the odds of a birth (including live births, stillbirths and pregnancy terminations) with congenital heart defect (cases) 
relative to the odds of a birth with one of the malformed controls (club-foot, angioma, skin abnormality,polydactyly, syndactyly and congenital 
hip dislocation)
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